|
1
|
Kolak A, Kamińska M, Sygit K, Budny A,
Surdyka D, Kukiełka-Budny B and Burdan F: Primary and secondary
prevention of breast cancer. Ann Agric Environ Med. 24:549–553.
2017.PubMed/NCBI
|
|
2
|
Liedtke C, Bernemann C, Kiesel L and Rody
A: Genomic profiling in triple-negative breast cancer. Breast Care
(Basel). 8:408–413. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosch A, Eroles P, Zaragoza R, Viña JR and
Lluch A: Triple-negative breast cancer: Molecular features,
pathogenesis, treatment and current lines of research. Cancer Treat
Rev. 36:206–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yadav BS, Sharma SC, Chanana P and Jhamb
S: Systemic treatment strategies for triple-negative breast cancer.
World J Clin Oncol. 5:125–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiao Q, Wu A, Shao G, Peng H, Wang M, Ji
S, Liu P and Zhang J: The latest progress in research on triple
negative breast cancer (TNBC): Risk factors, possible therapeutic
targets and prognostic markers. J Thorac Dis. 6:1329–1335.
2014.PubMed/NCBI
|
|
6
|
Meng Z, Garrett CR, Shen Y, Liu L, Yang P,
Huo Y, Zhao Q, Spelman AR, Ng CS, Chang DZ and Cohen L: Prospective
randomised evaluation of traditional Chinese medicine combined with
chemotherapy: A randomised phase II study of wild toad extract plus
gemcitabine in patients with advanced pancreatic adenocarcinomas.
Br J Cancer. 107:411–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li YC: A Concise Dictionary of Traditional
Chinese Medicine. People's Medical Publishing Press; Beijing: pp.
9001979
|
|
8
|
Jin SR, Zhu BD and Qin XH: Comparative
study of anti-tumors effects of Xi huang pellet by different
processing methods. Shi Zhen Guo Yi Guo Yao. 19:1735–1737.
2008.
|
|
9
|
Pan G, Wang W, Wang L, Zhang F, Yin X,
Wang J and Liang R: Anti-breast cancer effects and mechanisms of
Xihuang pill on human breast cancer cell lines. J Tradit Chin Med.
33:770–778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
You S, Li W and Guan Y: Tunicamycin
inhibits colon carcinoma growth and aggressiveness via modulation
of the ERK-JNK-mediated AKT/mTOR signaling pathway. Mol Med Rep.
17:4203–4212. 2018.PubMed/NCBI
|
|
11
|
Wang W, Li N, Luo M, Zu Y and Efferth T:
Antibacterial activity and anticancer activity of Rosmarinus
officinalis L. essential oil compared to that of its main
components. Molecules. 17:2704–2713. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Budihardjo I, Oliver H, Lutter M, Luo X
and Wang X: Biochemical pathways of caspase activation during
apoptosis. Annu Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nicholson DW: Caspase structure,
proteolytic substrates, and function during apoptotic cell death.
Cell Death Differ. 6:1028–1042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Strasser A, Huang DC and Vaux DL: The role
of the bcl-2/ced-9 gene family in cancer and general implications
of defects in cell death control for tumourigenesis and resistance
to chemotherapy. Biochim Biophys Acta. 1333:F151–F178.
1997.PubMed/NCBI
|
|
16
|
Gao N, Budhraja A, Cheng S, Yao H, Zhang Z
and Shi X: Induction of apoptosis in human leukemia cells by grape
seed extract occurs via activation of c-Jun NH2-terminal kinase.
Clin Cancer Res. 15:140–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shapiro GI and Harper JW: Anticancer drug
targets: Cell cycle and checkpoint control. J Clin Invest.
104:1645–1653. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi EJ, Oh HM, Wee H, Choi CS, Choi SC,
Kim KH, Han WC, Oh TY, Kim SH and Jun CD: Eupatilin exhibits a
novel anti-tumor activity through the induction of cell cycle
arrest and differentiation of gastric carcinoma AGS cells.
Differentiation. 77:412–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng W, Han S, Jiang S, Pang L, Li X, Liu
X, Cao M and Li P: Multiple effects of Xihuang pill aqueous extract
on the Hs578T triple-negative breast cancer cell line. Biomed Rep.
5:559–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen JR, Zhu BD, Qin XH and Zhang XS:
Antitumous effects of Xi Huang Pellet on diverse human malignant
tumor cell strains (MDA-MB-231, SMMC7721, T24, HL-60, A549). J
Sichuan Traditional Chin Med. 24:10–13. 2006.
|
|
21
|
Wang M, Meng JY and He SF: Xihuang Pill ()
induces mesenchymal-epithelial transition and inhibits loss of
apicalbasal polarity in colorectal cancer cell through regulating
ZEB1-SCRIB loop. Chin J Integr Med. 20:751–757. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao H, Qin XH, Lai Y, Shen JR and Lai L:
Containing Xihuang Pill drug serum regulates growth of lung cancer
stem cells by controlling cyclin D1 of Wnt signaling pathway. Chin
J Exp Trad Med Form. 20:172–176. 2014.
|
|
23
|
Xu H, Cui LR and Liu JC: Study on the
effects of Xihuang Pill on the expression of Bcl-2 mRNA of mice
bearing H22. Modern Preventive Med. 38:2120–2121. 2011.
|
|
24
|
Li LF, Chen RS, Liu XM, Jin QW and Deng
XG: Mechanism of Xihuang Pill on inducing liver cancer cell
apoptosis. Chin Arch Trad Chin Med. 22:125–126. 2004.
|
|
25
|
Li-na SUN, Jing-yan MENG, Wei WANG,
Sen-lin YING, Dan LI, Zuo-ying MA and Yan-tao JIA: Effect of
Xihuang Pills on protein expressions of MMP-2 and MMP-9 in human
colorectal carcinoma LoVo cell. Tianjin J Traditional Chin Med.
29:378–380. 2012.
|
|
26
|
Wang YY, Ren YZ, Jiao Z, Zeng CQ, Gao WB
and Liang WB: The influence of Xihuang Pill on the formation of con
tumor-bearing mice. Pharmacol Clin Chin Materia Med. 30:11–13.
2014.
|
|
27
|
Si-feng WANG, Ke-chun LIU, Xi-min WANG,
Qiu-xia HE, Xue WANG, Xi-qiang CHEN and Yan-qiang YUAN: Effect of
Xihuang Pill on angiogenesis in Zebrafish embryo. Chin J Hospital
Pharm. 30:821–823. 2010.
|
|
28
|
Ma Jie, Guan Shuo, Yang Wei, Hu Junxia,
Zeng Changqian, Gao Wenbin and Liang Wengbo: Experimental study on
the effect of Xihuang Pill ethanol extract on immune function of
tumorbearing rats. Pharmacol Clinics of Chin Materia Medica.
29:124–126. 2013.
|
|
29
|
Guan S, Yang W, Hu JX, Ma J, Gao WB and
Liang WB: Effect of chloroform extract of Xihuang Pill on the
immune clearance function of tumor-bearing rats. Chin J Modern
Applied Pharm. 31:144–148. 2014.
|
|
30
|
Yang Wei, Guan Shuo, Hu Junxia, Zeng
Changqian, Liang Wenbo, Ma Jie and Gao Wenbin: Experimental study
on antitumor effect of volatile oil of Xihuang Pill and its immune
mechanism. World Sci Technol-Modern of Trad Chin Med. 16:68–72.
2014.
|
|
31
|
Rebecca SY and Wong: Apoptosis in cancer:
From pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo Q, Lin J, Liu R, Gao Y, He S, Xu X,
Hua B, Li C, Hou W, Zheng H and Bao Y: Review on the applications
and molecular mechanisms of xihuang pill in tumor treatment. Evid
Based Complement Alternat Med. 2015:8543072015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu D and An GY: Clinical effects of
xihuang pill combined with chemotherapy in patients with advanced
colorectal cancer. Evid Based Complement Alternat Med.
2017:59360862017. View Article : Google Scholar : PubMed/NCBI
|
